These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32036300)

  • 1. Pharmacokinetics, tissue distribution, and safety evaluation of a ligustilide derivative (LIGc).
    Zhang Y; Zhang Y; Han Y; Tian Y; Wu P; Xin A; Wei X; Shi Y; Zhang Z; Su G; Shi Y; Liu J
    J Pharm Biomed Anal; 2020 Apr; 182():113140. PubMed ID: 32036300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPLC method with fluorescence detection for the determination of ligustilide in rat plasma and its pharmacokinetics.
    Zhang XY; Qiao H; Shi YB
    Pharm Biol; 2014 Jan; 52(1):21-30. PubMed ID: 24044763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS.
    Yang T; Shi Y; Lin C; Yan C; Zhang D; Lin J
    Eur J Pharm Sci; 2019 Apr; 131():146-152. PubMed ID: 30776467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress studies on pharmacology and pharmacokinetics of ligustilide].
    Zuo AH; Wang L; Xiao HB
    Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(22):3350-3. PubMed ID: 23373200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with Z-ligustilide, a component of Angelica sinensis, reduces brain injury after a subarachnoid hemorrhage in rats.
    Chen D; Tang J; Khatibi NH; Zhu M; Li Y; Wang C; Jiang R; Tu L; Wang S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):663-72. PubMed ID: 21398513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, brain distribution, release and blood-brain barrier transport of Shunaoxin pills.
    Wu K; Wang ZZ; Liu D; Qi XR
    J Ethnopharmacol; 2014 Feb; 151(3):1133-1140. PubMed ID: 24373808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat.
    Yan R; Ko NL; Li SL; Tam YK; Lin G
    Drug Metab Dispos; 2008 Feb; 36(2):400-8. PubMed ID: 18039808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Z-ligustilide: A review of its pharmacokinetics and pharmacology.
    Xie Q; Zhang L; Xie L; Zheng Y; Liu K; Tang H; Liao Y; Li X
    Phytother Res; 2020 Aug; 34(8):1966-1991. PubMed ID: 32135035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.
    Yang F; Lin ZW; Huang TY; Chen TT; Cui J; Li MY; Hua YQ
    Sci Rep; 2019 May; 9(1):6991. PubMed ID: 31061445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Pretreatment with Z-Ligustilide, the Main Volatile Component of Rhizoma Chuanxiong, Confers Prophylaxis against Cerebral Ischemia via Nrf2 and HSP70 Signaling Pathways.
    Li J; Yu J; Ma H; Yang N; Li L; Zheng DD; Wu MX; Zhao ZL; Qi HY
    J Agric Food Chem; 2017 Mar; 65(8):1533-1542. PubMed ID: 28169530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postischemic administration of Z-Ligustilide ameliorates cognitive dysfunction and brain damage induced by permanent forebrain ischemia in rats.
    Kuang X; Du JR; Liu YX; Zhang GY; Peng HY
    Pharmacol Biochem Behav; 2008 Jan; 88(3):213-21. PubMed ID: 17889286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice.
    Kuang X; Yao Y; Du JR; Liu YX; Wang CY; Qian ZM
    Brain Res; 2006 Aug; 1102(1):145-53. PubMed ID: 16806112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexation of Z-ligustilide with hydroxypropyl-β-cyclodextrin to improve stability and oral bioavailability.
    Lu Y; Liu S; Zhao Y; Zhu L; Yu S
    Acta Pharm; 2014 Jun; 64(2):211-22. PubMed ID: 24914721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angelica sinensis and its alkylphthalides induce the detoxification enzyme NAD(P)H: quinone oxidoreductase 1 by alkylating Keap1.
    Dietz BM; Liu D; Hagos GK; Yao P; Schinkovitz A; Pro SM; Deng S; Farnsworth NR; Pauli GF; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2008 Oct; 21(10):1939-48. PubMed ID: 18808158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression.
    Wang D; Li J; Feng W; Yao J; Ou L; Liao S; Liu Y; Li B; Lin C; Zhao J; Zhao G
    J Cell Biochem; 2019 Nov; 120(11):18667-18677. PubMed ID: 31436338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro.
    Peng B; Zhao P; Lu YP; Chen MM; Sun H; Wu XM; Zhu L
    Brain Res; 2013 Jul; 1520():168-77. PubMed ID: 23688544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and identification of the ligustilide compounds from the root of Angelica sinensis].
    Lu XH; Liang H; Zhao YY
    Zhongguo Zhong Yao Za Zhi; 2003 May; 28(5):423-5. PubMed ID: 15139126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of Z-ligustilide nanoemulsion.
    Ma Z; Bai L
    Inflammation; 2013 Apr; 36(2):294-9. PubMed ID: 23007925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of analytical and preparative high-speed counter-current chromatography for the separation of Z-ligustilide from a crude extract of Angelica sinensis.
    Wang X; Shi X; Li F; Liu J; Cheng C
    Phytochem Anal; 2008; 19(3):193-7. PubMed ID: 18200604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Z-ligustilide from Radix Angelica sinensis and human serum albumin.
    Chen T; Zhu X; Chen Q; Ge M; Jia X; Wang X; Ge C
    Food Chem; 2015 Nov; 186():292-7. PubMed ID: 25976824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.